Related Experiment Video
Updated: Sep 23, 2025

Intravitreal Injection and Quantitation of Infection Parameters in a Mouse Model of Bacterial Endophthalmitis
Published on: February 6, 2021
Cryptococcus laurentii endogenous endophthalmitis post COVID-19 infection
Muthugaduru Jagadish Deepa1, Chitta Megharaj2, Santosh Patil3
1Vitreo-Retina Services, Adarsh Super Speciality Eye Hospital, Shimoga, India.
A rare case of Cryptococcus laurentii endophthalmitis in a diabetic patient is presented. Prompt diagnosis and treatment with voriconazole led to improved vision, highlighting the importance of considering fungal causes in non-resolving eye infections.
Area of Science:
- Ophthalmology
- Infectious Diseases
- Mycology
Background:
- Endogenous endophthalmitis is a severe intraocular infection.
- Diabetes and recent infections are risk factors for endogenous endophthalmitis.
- Bacterial causes are more common, but fungal etiologies must be considered.
Observation:
- A diabetic male presented with progressive blurred vision and dense vitritis.
- Initial treatment for bacterial endophthalmitis was unsuccessful.
- Worsening symptoms and retinal deposits suggested an alternative diagnosis.
Findings:
- Repeat vitreous biopsy and culture identified *Cryptococcus laurentii* as the causative agent.
- Intravitreal voriconazole was administered for suspected fungal endophthalmitis.
- *Cryptococcus laurentii* is a rare cause of endogenous endophthalmitis.
Implications:
- This case highlights the importance of a broad differential diagnosis in endophthalmitis.
- Early identification and targeted antifungal therapy are crucial for visual recovery.
- Ophthalmologists should consider fungal infections, particularly *Cryptococcus*, in complex endophthalmitis cases.
More Related Videos
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Endocarditis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Glaucoma: Overview
Angle Closure Glaucoma: Treatment
Endocarditis III: Medical Management

